About
We are developing state-of-the-art minimally invasive surgical methodologies for treating structural heart diseases like Tricuspid Regurgitation (TR), Mitral Regurgitation (MR). And we We have finished first-in-man study and Early Feasibility Study of Pivot Bridge, a trans-catheter device for treating TR. We are based in Korea and the U.S.A. For more details, please visit our web site and refer the articles.
Technologies
GmailGoogle AppsGoogle Cloud HostingNginxVarnishMobile FriendlyGoogle Tag ManagerWixYouTubeAI
Keywords
medical devicecatheterheart diseaseheart valvestructural heart diseasemrtrhocmtricuspid regurgitationttvittvrcatheter-based therapiesmedical equipment and supplies manufacturingself-centering valve supportdevice customizationtranscatheter tricuspid supportservicesself-centering cardiac devicecatheter delivery systemflow-guided support systemself-centering supportflow-guided anchoringflow-guided supportnon-penetrating anchorssaline-filled spacer technologyreversible implantcardiovascular devicesflow stabilityreversible cardiac devicesheart valve therapy
Company Information
- Employees18
- Founded2014
Location
Yangsan, Gyeongsangnam-do, South Korea, 626-810
